ABCL
Abcellera Biologics Inc
$4.01
Earnings Summary
Revenue | $9.18Mn |
Net Profits | $-47.15Mn |
Net Profit Margins | -513.67% |
Highlights
Abcellera Biologics Inc’s revenue fell -57.4% since last year same period to $9.18Mn in the Q4 2023. On a quarterly growth basis, Abcellera Biologics Inc has generated 39.1% jump in its revenue since last 3-months.
Abcellera Biologics Inc’s net profit fell -57.73% since last year same period to $-47.15Mn in the Q4 2023. On a quarterly growth basis, Abcellera Biologics Inc has generated -64.8% fall in its net profits since last 3-months.
Abcellera Biologics Inc’s net profit margin fell -270.22% since last year same period to -513.67% in the Q4 2023. On a quarterly growth basis, Abcellera Biologics Inc has generated -18.48% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Abcellera Biologics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.16 |
EPS Estimate Current Year | -0.16 |
Highlights
Abcellera Biologics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.16 - a -23.08% fall from last quarter’s estimates.
Abcellera Biologics Inc’s earning per share (EPS) estimates for the current year stand at -0.16.
Key Ratios
Key ratios of the Abcellera Biologics Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.17 |
Highlights
Abcellera Biologics Inc’s earning per share (EPS) fell -70% since last year same period to -0.17 in the Q4 2023. This indicates that the Abcellera Biologics Inc has generated -70% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-02 | -0.13 | -0.1 | 23.08% |
2023-05-04 | -0.14 | -0.14 | 0% |
2023-08-03 | -0.13 | -0.11 | 15.38% |
2024-02-20 | -0.13 | -0.17 | -30.77% |
₹0 US Stocks a/c Opening Fee